Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
1, a novel core-shell self-assembly method catalyzed via thiol-disulfide exchange reactions was presented, which was employed to target GSH and trigger the HCR reaction for intracellular GSH monitoring
What conditions does IV therapy treat
The FDA has specifically flagged risks including dosing errors, variable concentrations, improper storage during shipping, quality control differences, limited adverse-event reporting, and products falsely marketed for research or non-human-use purposes
Reconstitution starts the stability clock
US$ 24.30
US$ 27.83
US$ 25.38
US$ 27.57
